Breaking News
Get 40% Off 0
Join +750K new investors every month who copy stock picks from billionaire's portfolios Sign Up Free
Close

Merck & Company Inc (MRK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Merck&Co historical data, for real-time data please try another search
69.60 0.00    0.00%
02/10 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 68.60 - 69.60
Type:  Equity
Market:  Germany
ISIN:  US58933Y1055 
S/N:  A0YD8Q
Merck&Co 69.60 0.00 0.00%

NYSE:MRK Financials

 
This summary provides an overview of the most significant critical numbers from each of the Merck financial reports, including theMerck income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NYSE:MRK financials over time via breakdowns of their annual reports.

For the six months ended 30 June 2016, Merck & Co., Inc. revenues decreased less than 1% to $19.16B. Net income increased 42% to $2.33B. Revenues reflect All Other segment increase of 5% to $905M, also reflect Merck Pharmaceutical segment decrease of 5% to $8.1B, Unallocated segment decrease of 17% to $303M. Net income benefited from Marketing and Administrative decrease of 52% to $2.31B (expense).

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MRK Income Statement & Profits

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014
Total Revenue 9785 9425 10482 10557
Gross Profit 7377 7211 6838 6421
Operating Income 1546 1435 1176 1324
Net Income 687 952 7316 895

MRK Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014
Total Assets 108345 98335 101808
Total Liabilities 60580 49688 56584
Total Equity 47765 48647 45224

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014
Period Length: 0 Months 3 Months 12 Months 9 Months
Cash From Operating Activities 2284 7860 9024
Cash From Investing Activities -6605 -374 -7578
Cash From Financing Activities 5155 -15113 -5470
Net Change in Cash 539 -8180 -4251
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRK Price Commentary

Write your thoughts about Merck KGAA O.N.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Apr 19, 2022 20:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
down today because stupid like cow as dow jones components
Melvin Lim
Melvin Lim Oct 06, 2021 17:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just started. More to go!
Alan Ng
Alan Ng Sep 23, 2021 15:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it is going up
Tim Lo
Tim Lo Feb 22, 2021 16:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happen to MRK ? Time to buy ?
amit saxena
amit saxena Oct 15, 2020 18:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will cross 81 in coming days
Ali Asghar
Ali Asghar Oct 15, 2020 18:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello
Mike Pieri
Mike Pieri Mar 04, 2019 2:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The immuno-oncology drugs are promising, but $81.65 seems a bit over-excited. It's no cure, just prolonging life a small amount in end-stage patients who were resistant to normal treatments. A pullback to $70 on the cards in the next 6months would be realistic.
Sukumar Jain
Sukumar Jain Mar 04, 2019 2:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice input
Sukumar Jain
Sukumar Jain Mar 04, 2019 2:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice input
Hossein Taheri
Hossein Taheri Jan 31, 2019 22:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It will be going up
jordan rrk
jordan rrk Dec 26, 2017 8:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Position buy will be up price
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email